X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Abbott India Quarterly Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Abbott India Quarterly Results   (KNOL)

Here are the latest quarterly results of Abbott India. For more details, see the Abbott India financial fact sheet and Abbott India share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Abbott India Quarterly Results

No. of Mths
Qtr. Ending
3
Jun-15
3
Sep-15
3
Dec-15
3
Mar-16
3
Jun-16
3
Sep-16
3
Dec-16
3
Mar-17
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m6,3316,4516,6736,8307,3817,2947,5577,154 
Other income Rs m125131124126139144139155 
Turnover Rs m6,4566,5816,7966,9567,5217,4387,6967,309 
Expenses Rs m5,3735,5885,6516,0076,3276,2346,3276,526 
Gross profit Rs m9588631,0228231,0541,0601,231629 
Depreciation Rs m3434364142414438 
Interest Rs m041300020 
Profit before tax Rs m1,0499551,1099051,1521,1631,326725 
Tax Rs m363338405315412412470304 
Profit after tax Rs m686617704590740750856421 
Gross profit margin %15.113.415.312.114.314.516.38.8 
Effective tax rate %34.635.436.534.835.735.535.542.0 
Net profit margin %10.89.610.58.610.010.311.35.9 
Diluted EPS Rs 32.3 29.0 33.1 27.8 34.8 35.3 40.3 19.8  
Diluted EPS (TTM) Rs 116.0 115.1 117.8 122.2 124.7 131.0 138.2 130.2  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

More Pharmaceuticals Company Quarterly Results:   SHASUN PHARMA  PFIZER  INDOCO REMEDIES  TORRENT PHARMA  ORCHID PHARMA LTD  

Compare ABBOTT INDIA With:   SHASUN PHARMA  PFIZER  INDOCO REMEDIES  TORRENT PHARMA  ORCHID PHARMA LTD  

Compare ABBOTT INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Hits 32,500 in Morning Trade; HCL Tech Surges 3.6%(09:30 am)

Asian equity markets are mixed today. The Nikkei 225 is up 0.22%, while the Hang Seng is up 0.37%. The Shanghai Composite is trading lower by 0.35%.

Views on news

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Glenmark Pharma: Lower Zetia Sales leads to Subdued Growth (Quarterly Results Update - Detailed)

May 18, 2017

Base price erosion in the US and lower Zetia sales impacts profits.

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

More Views on News

Most Popular

Ride the Bull Wave with These Perfect Proxies to India's Growth Story(The 5 Minute Wrapup)

Jul 15, 2017

The secret of spotting multibaggers before they become a hit.

The Real Returns from Real Estate Have Been Very Low(Vivek Kaul's Diary)

Jul 17, 2017

Real estate prices across India have barely gone anywhere over the last four years. Prices have fallen in many cities over the last one-year, new data from the National Housing Bank suggests.

Trade the Markets like Roger Federer Plays Tennis(Daily Profit Hunter)

Jul 19, 2017

Trading is one of the most competitive fields in the world today. To win, you must adopt the mindset of a Grand Slam champion.

Sold Your Immoveable Property? Here Are The Tax Implications...(Outside View)

Jul 19, 2017

When you're selling an immoveable property, it becomes imperative to recognise the intricate tax implications.

Why Keeping Unrealistic Expectations From Investments Is Stupid!(Outside View)

Jul 18, 2017

When investing, keeping realistic returns is necessary and it is not the only thing you should look at.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Jul 27, 2017 10:09 AM

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ABBOTT INDIA

ABBOTT INDIA 5-YR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS